Platelet Volume Is Reduced In Metastasing Breast Cancer: Blood Profiles Reveal Significant Shifts

References

• DeSantis CE, Ma J, Goding SA, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67:439–448. doi:10.3322/caac.2141228972651
   PubMed Web of Science ®Google Scholar
• Bale R, Putzer D, Schullian P. Local treatment of breast cancer liver metastasis. Cancers (Basel). 2019;11:1341.
   PubMed Web of Science ®Google Scholar
• Polivka J, Kralickova M, Polivka J, Kaiser C, Kuhn W, Golubnitschaja O. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon. EPMA J. 2017;8:119–127. doi:10.1007/s13167-017-0087-528824737
   PubMed Web of Science ®Google Scholar
• Smokovski I, Risteski M, Polivka J, et al. Postmenopausal breast cancer: European challenge and innovative concepts. EPMA J. 2017;8:159–169. doi:10.1007/s13167-017-0094-628824739
   PubMed Web of Science ®Google Scholar
• Fröhlich H, Patjoshi S, Yeghiazaryan K, Kehrer C, Kuhn W, Golubnitschaja O. Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification. EPMA J. 2018;9:175–186. doi:10.1007/s13167-018-0131-029896316
   PubMed Web of Science ®Google Scholar
• Zubor P, Kubatka P, Kajo K, et al. Why the gold standard approach by mammography demands extension by multiomics? Application of liquid biopsy miRNA profiles to breast cancer disease management. Int J Mol Sci. 2019;20:2878.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Aiura K, Kitagou M, et al. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology. 2004;51(57):847–853.15143932
   PubMedGoogle Scholar
• Qiu J, Yu Y, Fu Y, Ye F, Xie X, Lu W. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res. 2012;38(4):651–657. doi:10.1111/j.1447-0756.2011.01780.x22413879
   PubMed Web of Science ®Google Scholar
• Ekici H, Malatyalioglu E, Kokcu A, Kurtoglu E, Tosun M, Celik H. Do leukocyte and platelet counts have benefit for\preoperative evaluation of endometrial cancer. Asian Pac J Cancer Prev. 2015;16(13):5305–5310. doi:10.7314/apjcp.2015.16.13.530526225670
   PubMedGoogle Scholar
• Long Y, Wang T, Gao Q, Zhou C. Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis. Oncotarget. 2016;7. doi:10.18632/oncotarget.v7i49
   Google Scholar
• Pietrzyk L, Plewa Z, Denisow-Pietrzyk M, Zebrowski R, Torres K. Diagnostic power of blood parameters as screening markers in gastric cancer patients. Asian Pac J Cancer Prev. 2016;17(9):4433–4437.27797257
   PubMedGoogle Scholar
• Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019;2019:9213074. doi:10.1155/2019/921307431148950
   PubMed Web of Science ®Google Scholar
• Kemal Y, Demirağ G, Ekiz K, Yücel I. Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer. J Obstet Gynaecol. 2014;34:515–518. doi:10.3109/01443615.2014.91262024832894
   PubMedGoogle Scholar
• Kumagai S, Tokuno J, Ueda Y, et al. Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer. Mol Clin Oncol. 2015;3:197–201. doi:10.3892/mco.2014.43625469294
   PubMed Web of Science ®Google Scholar
• Shen XM, Xia YY, Lian L, et al. Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer. Oncol Lett. 2016;12:2501–2506. doi:10.3892/ol.2016.491327703523
   PubMed Web of Science ®Google Scholar
• Tanriverdi O, Menekse S, Teker F, et al. The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG). J Buon. 2016;21:840–850.27685904
   PubMed Web of Science ®Google Scholar
• Gresele P, Momi S, Malvestiti M, Sebastiano M. Platelet-targeted pharmacologic treatments as anti-cancer therapy. Cancer Metastasis Rev. 2017;36:331–355. doi:10.1007/s10555-017-9679-828707198
   PubMed Web of Science ®Google Scholar
• Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res. 2005;7(5):R78895. doi:10.1186/bcr949
   Web of Science ®Google Scholar
• Kang DW, Min D. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells. Cancer Lett. 2010;294(1):125–133. doi:10.1016/j.canlet.2010.01.03120188462
   PubMed Web of Science ®Google Scholar
• Boucharaba A, Serre CM, Grès S, et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest. 2004;114(12):1714–1725. doi:10.1172/JCI2212315599396
   PubMed Web of Science ®Google Scholar
• Jiang L, Luan Y, Miao X, et al. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling. Br J Cancer. 2017;117:695–703. doi:10.1038/bjc.2017.21428697175
   PubMed Web of Science ®Google Scholar
• Gareau AJ, Brien C, Gebremeskel S, Liwski RS, Johnston B, Bezuhly M. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. Clin Exp Metastasis. 2018;35:25–35. doi:10.1007/s10585-018-9874-129322294
   PubMed Web of Science ®Google Scholar
• Xu XR, Yousef GM, Ni H. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood. 2018;131:1777–1789. doi:10.1182/blood-2017-05-74318729519806
   PubMed Web of Science ®Google Scholar
• Wang S, Li Z, Xu R. Human cancer and platelet interaction, a potential therapeutic target. Int J Mol Sci. 2018;19:1246.
   PubMed Web of Science ®Google Scholar
• Lavergne M, Janus-Bell E, Schaff M, Gachet C, Mangin PH. Platelet integrins in tumor metastasis: do they represent a therapeutic target? Cancers (Basel). 2017;9:133. doi:10.3390/cancers9100133
   PubMed Web of Science ®Google Scholar
• Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11:125. doi:10.1186/s13045-018-0669-230305116
   PubMed Web of Science ®Google Scholar
• Huong PT, Nguyen LT, Nguyen X-B, Lee SK, Bach D-H. The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells. Cancers (Basel). 2019;11:240. doi:10.3390/cancers11020240
   PubMed Web of Science ®Google Scholar
• Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy. Asian Pac J Cancer Prev. 2014;15:6421–6423. doi:10.7314/apjcp.2014.15.15.642125124636
   PubMed Web of Science ®Google Scholar
• Gu M, Zhai Z, Huang L, et al. Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer. Breast Cancer. 2016;23:752–760. doi:10.1007/s12282-015-0635-626306738
   PubMed Web of Science ®Google Scholar
• Lian L, Xia YY, Zhou C, et al. Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer. Oncol Lett. 2015;10:3419–3424. doi:10.3892/ol.2015.378426788144
   PubMed Web of Science ®Google Scholar
• Palacios-Acedo AL, Mège D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Platelets, thrombo-inflammation, and cancer: collaborating with the enemy. Front Immunol. 2019;10:1805. doi:10.3389/fimmu.2019.0180531417569
   PubMed Web of Science ®Google Scholar
• Golubnitschaja O, Yeghiazaryan K, Stricker H, Trog D, Schild HH, Berliner L. Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer. 2016;16:357. doi:10.1186/s12885-016-2382-227277077
   PubMed Web of Science ®Google Scholar
• Golubnitschaja O, Polivka J, Yeghiazaryan K, Berliner L. Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach. EPMA J. 2018;9:271–285. doi:10.1007/s13167-018-0146-630174763
   PubMed Web of Science ®Google Scholar
• Zubor P, Kubatka P, Dankova Z, et al. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer. Future Oncol. 2018;14:1847–1867. doi:10.2217/fon-2018-006130019928
   PubMed Web of Science ®Google Scholar
• Golubnitschaja O, Filep N, Yeghiazaryan K, Blom HJ, Hofmann-Apitius M, Kuhn W. Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine. Amino Acids. 2018;50:383–395. doi:10.1007/s00726-017-2524-029249020
   PubMed Web of Science ®Google Scholar